Codexis Inc CDXS:NASDAQ

Last Price$10.56NASDAQ Previous Close - Last Trade as of 3:59PM ET 4/08/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$8.00 (12)
Ask (Size)$14.75 (2)
Day Low / HighN/A - N/A
Volume246.4 K
 

View Chemicals: Specialty IndustryPeer Comparison as of 04/08/2020

 

Codexis Inc ( NASDAQ )

Price: $10.56
Change: +0.44 (4.35%)
Volume: 246.4 K
3:59PM ET 4/08/2020
 
 

FutureFuel Corp ( NYSE )

Price: $12.75
Change: +0.06 (0.47%)
Volume: 226.9 K
6:30PM ET 4/08/2020
 
 

Westlake Chemical Partners LP ( NYSE )

Price: $15.75
Change: 0.00 (0.00%)
Volume: 41.4 K
6:30PM ET 4/08/2020
 
 

Tronox Holdings PLC ( NYSE )

Price: $5.34
Change: +0.57 (11.95%)
Volume: 1.7 K
6:30PM ET 4/08/2020
 
 

Orion Engineered Carbons SA ( NYSE )

Price: $7.69
Change: +0.69 (9.86%)
Volume: 2.6 M
6:30PM ET 4/08/2020
 

Read more news Recent News

Insider Trends: Codexis Insider Extends 90-Day Selling Trend
4:11PM ET 4/03/2020 MT Newswires

Thomas R Baruch, Director, sold 15,000 shares of Codexis (CDXS) on Apr 01, 2020, for $160,442. Subsequent to the Form 4 filing with the SEC, Baruch has...

Insider Trends: Codexis Insider Extends 90-Day Selling Trend
4:44PM ET 3/27/2020 MT Newswires

Dennis P Wolf, Director, sold 10,000 shares of Codexis (CDXS) on Mar 25, 2020, for $103,785. Subsequent to the Form 4 filing with the SEC, Wolf owns...

Codexis, Takeda Sign Strategic Collaboration, License Deal to Create Gene Therapies for Rare Genetic Disorders
7:34AM ET 3/23/2020 MT Newswires

Codexis (CDXS), a protein engineering company, has signed a strategic collaboration and license agreement with Takeda Pharmaceutical to research and...

--Analyst Actions: Benchmark Capital Initiates Coverage on Codexis With Buy Rating
8:02AM ET 3/10/2020 MT Newswires

Price: 11.43, Change: -0.64, Percent Change: -5.30 ...

View all Commentary and Analysis

Codexis, Inc. (CDXS) CEO John Nicols on Q4 2019 Results - Earnings Call Transcript
10:16PM ET 2/27/2020 Seeking Alpha

Codexis, Inc. 2019 Q4 - Results - Earnings Call Presentation
7:15PM ET 2/27/2020 Seeking Alpha

Alibaba And Disney Step Out (Stocks To Watch Podcast)
7:30AM ET 11/10/2019 Seeking Alpha

Stocks To Watch: Alibaba And Disney Step Out
7:09AM ET 11/09/2019 Seeking Alpha

Company Profile

Business DescriptionCodexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA. View company web site for more details
Address200 Penobscot Drive
Redwood City, California 94063-4718
Phone+1.650.421.8100
Number of Employees132
Recent SEC Filing04/03/20204
President, Chief Executive Officer & DirectorJohn J. Nicols
Senior VP, Chief Financial & Accounting OfficerRoss Taylor
VP-Bio Therapeutics Research & DevelopmentHicham Alaoui
Senior Director-Molecular DiagnosticsShawn Clairmont

Company Highlights

Price Open$10.26
Previous Close$10.56
52 Week Range$8.43 - 21.72
Market Capitalization$622.0 M
Shares Outstanding58.9 M
SectorProcess Industries
IndustryChemicals: Specialty
Next Earnings Announcement05/04/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.21
Beta vs. S&P 500N/A
Revenue$60.6 M
Net Profit Margin-17.43%
Return on Equity-13.34%

Analyst Ratings as of 03/09/2020

Buy
5
Overweight
1
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset